Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma

María Inés Molejon; Mirna Swayden; Daniele Fanale; Jennifer Bintz; Odile Gayet; Philippe Soubeyran; Juan Iovanna

doi:10.18632/oncotarget.25745

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma

María Inés Molejon, Mirna Swayden, Daniele Fanale, Jennifer Bintz, Odile Gayet, Philippe Soubeyran and Juan Iovanna _

PDF | HTML | How to cite

Oncotarget. 2018; 9:30837-30846. https://doi.org/10.18632/oncotarget.25745

Metrics: PDF 1640 views | HTML 2184 views | ?

Abstract

María Inés Molejon1,2,*, Mirna Swayden1,*, Daniele Fanale3, Jennifer Bintz1, Odile Gayet1, Philippe Soubeyran1 and Juan Iovanna1

1Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France

2INCITAP-CONICET (Instituto de Ciencias de la Tierra y Ambientales - Consejo Nacional de Investigaciones Científicas y Técnicas), Facultad de Ciencias Exactas y Naturales, Universidad Nacional de La Pampa (UNLPam), Santa Rosa, La Pampa, Argentina

3Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy

*These authors have contributed equally to this work

Correspondence to:

Juan Iovanna, email: [email protected]

Keywords: pancreas cancer; autophagy; Chloroquine; gemcitabine

Received: April 23, 2018 Accepted: June 23, 2018 Published: July 20, 2018

ABSTRACT

In this study, our aim is to assess the role played by autophagy and its inhibition in the different PDAC cellular compartments, and its involvement in chemo-resistance using primary human pancreatic cancer-derived cells (PCC) and Cancer Associated Fibroblasts (CAF). Autophagy flux, as measured by LC3-I and -II in the presence of Chloroquine, showed a variable level in PCC and CAFs. We found no correlation between autophagy level and degree of tumor differentiation. Association of Chloroquine with gemcitabine, 5FU, oxaliplatin, irinotecan and docetaxel revealed that its effect on survival is cell- and drug-dependent in vitro and in vivo. In addition, we demonstrated that autophagy in CAFs can play an important role in sensitizing PDAC to anticancer treatments since its inhibition increased the resistance of PCCs to gemcitabine. In conclusion, this work clearly shows a heterogeneity in the effect of Chloroquine and highlights a role of CAFs autophagy in sensitizing tumors to treatments. It also reveals that the role of autophagy is more complex than expected in PDAC as well as its sensitivity to treatments.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25745

Publication Alerts

Research Papers:

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma

Abstract